Menten AI
YC W20 · Active · Menten AI designs peptide and protein therapeutics using quantum…
Competitors
Adjacent
Also from W20 in AI
All of W20About Menten AI
Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.
- YC batch
- W20 · Winter 2020
- Status, per YC
- Active
- Category
- AI
- Team size
- 2
- Location
- San Francisco, CA, USA
- Checked
- 34m ago
YC tags: AI-powered Drug Discovery, Quantum Computing
Menten AI: questions
Which YC batch was Menten AI in?
Menten AI was in Y Combinator's Winter 2020 batch (W20).
Is Menten AI still active?
Y Combinator lists Menten AI as active.
Where is Menten AI based?
Menten AI lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.